Department of Surgery, University of Hong Kong, Queen Mary Hospital, Hong Kong, China.
Liver Transpl. 2011 Feb;17(2):115-21. doi: 10.1002/lt.22034.
The middle hepatic vein may be included in right liver living donor liver transplantation (LDLT) to optimize hepatic venous outflow. We studied the graft's ability to relieve portal hypertension and accommodate portal hyperperfusion with portal manometry and ultrasonic flowmetry. Surgical outcomes with respect to portal hemodynamometry were also investigated. The ages of the recipients and donors for 46 consecutive LDLT procedures were 50 (range, 16-66 years) and 31 years (range, 18-54 years), respectively. The graft to standard liver volume ratio was 47.4% (range, 32.4%-69.0%). The hospital mortality rate was 4.4% as 2 recipients died from a subarachnoid hemorrhage and sepsis. The portal pressure dropped by 8 mm Hg (range, -7 to 19 mm Hg) from 23 (range, 8-37 mm Hg) to 14 mm Hg (range, 10-26 mm Hg) after graft implantation. The portal inflow positively correlated with the portal pressure before native liver hepatectomy (R(2) = 0.305, P = 0.001) and not with the graft size. The portal inflow increased from 81 mL/minute/100 g (range, 35-210 mL/minute/100 g) before donor right hepatectomy to 318 mL/minute/100 g (range, 102-754 mL/minute/100 g) after graft implantation. The graft portal inflow had a positive linear correlation with the recipient portal pressure before native liver total hepatectomy (R(2) = 0.261, P = 0.001) but not after graft implantation, and it had a negative correlation with the graft to standard liver volume ratio (R(2) = 0.247, P = 0.001). Only 1 of the graft biopsies showed moderate sinusoidal congestion. Twelve recipients had Clavien grade 2+ complications that were not related to the portal inflow and pressure or graft size. Right liver LDLT including the middle hepatic vein effectively lowered the recipient portal pressure by allowing unimpeded venous outflow.
中肝静脉可用于右半肝活体肝移植(LDLT),以优化肝静脉流出。我们通过门静脉测压和超声流量计研究了移植物缓解门脉高压和适应门脉高灌注的能力。还研究了与门静脉血流动力学有关的手术结果。46 例连续 LDLT 手术的受者和供者年龄分别为 50 岁(范围,16-66 岁)和 31 岁(范围,18-54 岁)。供肝与标准肝体积比为 47.4%(范围,32.4%-69.0%)。2 例患者因蛛网膜下腔出血和脓毒症死亡,住院死亡率为 4.4%。移植物植入后门脉压从 23mmHg(范围,8-37mmHg)下降至 14mmHg(范围,10-26mmHg),下降 8mmHg(范围,-7 至 19mmHg)。在供肝右半肝切除术前,门静脉流入量与门脉压力呈正相关(R2=0.305,P=0.001),与供肝大小无关。供肝右半肝切除术前门静脉流入量为 81ml/min/100g(范围,35-210ml/min/100g),移植物植入后门静脉流入量增加至 318ml/min/100g(范围,102-754ml/min/100g)。在供肝全肝切除术前,移植物门静脉流入量与受者门脉压力呈正相关(R2=0.261,P=0.001),但在移植物植入后无相关性,与供肝与标准肝体积比呈负相关(R2=0.247,P=0.001)。仅有 1 例移植物活检显示中度窦状隙淤血。12 例受者发生 2 级及以上并发症,与门静脉流入量、压力或移植物大小无关。包括中肝静脉的右半肝 LDLT 通过允许通畅的静脉流出,有效地降低了受者的门脉压力。